Naglaa H. Shoukry, BPharm., PhD
Dr. Shoukry obtained her Pharmacy degree from Cairo University (1991) and Ph.D. in Immunology from McGill University (2000). Her postdoctoral research has established the essential and complementary roles of CD8 and CD4 T lymphocytes in resolution and protection from HCV infection. Since joining the Université de Montréal and CRCHUM in 2005, she has established a translational research program focused on studying immunity to HCV in people who inject drugs. Recently, her research has expanded to studying immunological mechanisms of liver fibrosis progression and development of liver cancer. She has published over 75 articles in high impact journals related to liver immunology and has received multiple awards from the American Liver Foundation, the Canadian Institutes of Health Research (CIHR) and Fonds de recherche du Québec – Santé (FRQS). Since 2015 she has been the Director of the Canadian Network on Hepatitis C (CanHepC), federally funded network with over 100 investigators, trainees and knowledge users working towards establishing a pipeline from research to implementation and to improve the lives of Canadians living with hepatitis C.